Deferasirox - a rarer cause of Fanconi syndrome

• Huvudskapare: Iman Khan (Författare, medförfattare), Mustafa Muhammad (Författare, medförfattare), Janki Patel (Författare, medförfattare)
• Materialtyp: Bok
• Publicerad: Greater Baltimore Medical Center, 2019-07-01T00:00:00Z.
• Ämnen: article
• Länkar: Connect to this object online.

Deferasirox is a recently approved iron chelator and is widely used to treat iron overload in transfusion-dependent patients. Its once-daily dosing and oral route of administration have made it an appealing alternative to deferoxamine. Recent case studies have brought to light its potential to cause...